High BMI linked to vascular dementia risk
High body mass index (BMI) could cause a higher risk of vascular-related dementia (a combination of vascular +…
6 New Weight Loss Drugs That Could Dethrone Ozempic
The arrival of semaglutide and similar GLP-1 drugs in recent years has ushered in a new era of…
Sperm RNA aging shift that may explain paternal age effects
A newly revealed “aging cliff” in sperm RNA marks a conserved molecular transition from youth to later life,…
Nutrition experts call for dietary fiber recognition as an essential nutrient
Ōtākou Whakaihu Waka nutrition experts are calling for dietary fiber to be officially recognised internationally as an essential…
Tracing the decline in American heart disease mortality
Following a five-year upward trend likely impacted by the COVID pandemic, the number of heart disease and stroke…
How “old RNA” reshapes sperm metabolism
Increasing paternal age has been linked to elevated health risks for the next generation, including higher risks of…
Lung cancer deaths leveling off for EU women, except in Spain
After increasing for more than 25 years, lung cancer death rates are finally levelling off among women in…
Only two years after stopping their obesity drugs, people are back to their original weight
While modern GLP-1 weight management drugs such as Ozempic, Wegovy, and Mounjaro represent a popular way to lose…
How Will Mounjaro and Zepbound Sales Aid LLY’s Upcoming Q4 Results?
Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its…
Thermogenic beige fat protects blood vessels from hypertension
Obesity causes hypertension. Hypertension causes cardiovascular disease. And cardiovascular disease is the leading cause of death worldwide. While…
Gut bacteria compound during pregnancy protects offspring from fatty liver disease
Children born to mothers who consume a high-fat, high-sugar diet during pregnancy and breastfeeding face a higher risk…
Tell-all book on Ozempic gets Galway launch
The inside story of the pharmaceutical industry’s efforts to tackle and monetise obesity with Ozempic and other drugs…